Repository of Research and Investigative Information

Repository of Research and Investigative Information

Ilam University of Medical Sciences

Effect of methyl jasmonate and 3-bromopyruvate combination therapy on mice bearing the 4 T1 breast cancer cell line

Thu Jun 13 23:36:35 2024

(2020) Effect of methyl jasmonate and 3-bromopyruvate combination therapy on mice bearing the 4 T1 breast cancer cell line. Journal of Bioenergetics and Biomembranes. pp. 103-111. ISSN 0145-479X

Full text not available from this repository.

Official URL: http://apps.webofknowledge.com/InboundService.do?F...

Abstract

Cancer cells apply the Warburg pathway to meet their increased metabolic demands caused by their rapid growth and proliferation and also creates an acidic environment to promote cancer cell invasion. 3-bromopyruvate (3-BrP) as an anti-cancer agent disrupts glycolytic pathway. Moreover, one of the mechanism of actions of Methyl Jasmonate (MJ) is interference in glycolysis. Hence, the aim of this study was to evaluate MJ and 3-BrP interaction. MTT assay was used to determine IC50 and synergistic concentrations. Combination index was applied to evaluate the drug- drug interaction. Human tumor xenograft breast cancer mice was used to evaluate drug efficacy in vivo. Tumor size was considered as a drug efficacy criterion. In addition to drug efficacy, probable side effects of these drugs including hepatotoxicity, renal failure, immunotoxicity, and losing weight were evaluated. Serum alanine aminotransferase and aspartate aminotransferase for hepatotoxicity, serum urea and creatinine level for the possibility of renal failure and changes in body weight were measured to evaluate drug toxicity. IL10 and TGF beta secretion in supernatant of isolated splenocytes from treated mice were assessed to check immunotoxicity. 3-BrP synergistically augmented the efficacy of MJ in the specific concentrations. This polytherapy was more effective than monotherapy of 3-BrP, MJ, and also surprisingly cyclophosphamide as a routine treatment for breast cancer in the tumor bearing mice. These results have been shown by decrease in tumor volume and increase of tumor growth inhibition percentage. This combination therapy didn't have any noticeable side effects on kidney, liver, and immune system and body weight.

Item Type: Article
Creators:
CreatorsEmail
Yousefi, S.UNSPECIFIED
Darvishi, P.UNSPECIFIED
Yousefi, Z.UNSPECIFIED
Pourfathollah, A. A.UNSPECIFIED
Keywords: 3-Bromopyruvate Methyl jasmonate Breast cancer Glycolysis Combination therapy cyclophosphamide stress proliferation biosynthesis metabolism apoptosis Biophysics Cell Biology
Divisions:
Page Range: pp. 103-111
Journal or Publication Title: Journal of Bioenergetics and Biomembranes
Journal Index: ISI
Volume: 52
Number: 2
Identification Number: https://doi.org/10.1007/s10863-019-09811-w
ISSN: 0145-479X
Depositing User: مهندس مهدی شریفی
URI: http://eprints.medilam.ac.ir/id/eprint/2601

Actions (login required)

View Item View Item